期刊文献+

接头蛋白Crk Ⅰ在喉鳞癌中的表达及意义

Expression and Significance of Crk Ⅰ in Laryngeal Squamous Cell Carcinoma
下载PDF
导出
摘要 目的:探讨接头蛋白Crk Ⅰ在喉鳞癌组织中的表达及意义;方法:采用免疫组化SP法,对54例喉鳞癌手术切除标本和22例癌旁正常组织进行检测,观察Crk Ⅰ在2种组织中的表达,分析Crk Ⅰ的表达与鳞癌临床分期、病理分级、肿瘤转移及生存时间的关系。结果:Crk Ⅰ在喉癌组织中主要表达于细胞质、细胞核可见少量表达、阳性率达64.8%,在癌旁正常组织中少量表达或无表达,2种组织中Crk Ⅰ表达阳性率比较,差异有统计学意义(χ~2=24.149,P<0.01);喉鳞癌组织中,有淋巴结转移者Crk Ⅰ蛋白阳性表达率为91.7%,与无淋巴结转移者的54.8%比较,差异有统计学意义(P<0.05);但Crk Ⅰ蛋白的阳性表达率在各年龄组、不同临床分期、病理分级及不同预后的喉鳞癌患者中比较差异无统计学意义(P>0.05)。结论:接头蛋白Crk Ⅰ可能在喉鳞癌细胞的发生、发展和转移中有重要意义。 Objective: To investigate the expression and significance of Crk Ⅰ in laryngeal squamous cell carcinoma. Methods: Fifty-four cases with laryngeal cancer were detected by immunohistochemistry S-P method and the ablated laryngeal squamous cell carcinoma samples and the normal para-carcinoma tissues were analyzed. Results: Analysis showed that the expression of Crk Ⅰgene in laryngeal squamous cell carcinoma was up-regulated. The difference of Crk Ⅰin the tissues and laryngeal carcinoma of the control group was statistically significant. There was significant difference in lymph node metastasis. Conclusion: Over-expression of Crk Ⅰmay play an important role in the oncogenesis,progression and metastasis of laryngeal carcinoma.
作者 于明 姚芝芬 龚正鹏 YU Ming;YAO Zhifen;GONG Zhengpeng(Department of Otorhinolaryngology Head and Neck Surgery,the Affiliated Baiyun Hospital of Guizhou Medical University,Guiyang 550014,Guizhou,China;Department of Otorhinolaryngology Head and Neck Surgery,the Affiliated Guizhou Medical University,Guiyang 550004,Guizhou,China)
出处 《贵州医科大学学报》 CAS 2018年第5期568-571,共4页 Journal of Guizhou Medical University
关键词 喉鳞癌 接头蛋白Crk 免疫组织化学染色 肿瘤 病理分级 基因表达 laryngeal squamous cell carcinoma Crk I immunohistochemistry neoplasms pathological grading gene expression
  • 相关文献

参考文献3

二级参考文献27

  • 1Feller SM. Crk family adaptors - signalling complex formation and biological roles [J]. Oncogene, 2001, 20 (44): 6348-6371.
  • 2Kiyokawa E, Hashimoto Y, Kobayashi S, et al. Activation of Racl by a Crk SH3 -binding protein, DOCK180 [J]. Genes Dev, 1998, 12 (21) : 3331 -3336.
  • 3Tanaka S, Morishita T, Hashimoto Y, et al. C3G, a guanine nueleotide - releasing protein expressed ubiquitously, binds to the Sro homology 3 domains of CRK and GRB2/ASH proteins [ J]. Proe Nail Aead Sei U S A, 1994, 91 (8) : 3443 -3447.
  • 4Vander Griend DJ, Rinker -Schaeffer CW. A new look at an old problem: the survival and organ - specific growth of metastases [ J]. Sci STKE, 2004, 2004 (216): 3.
  • 5Nishihara H, Tanaka S, Tsuda M, et al. Molecular and immunohistochemical analysis of signaling adaptor protein Crk in human cancers [J]. Cancer Lett, 2002, 180 (1): 55-61.
  • 6Takino T, Nakada M, Miyamori H, et al. CrkI adapter protein modulates cell migration and invasion in glioblastoma [ J]. Cancer Res, 2003, 63 (9) : 2335 -2337.
  • 7Gotoh T, Hattori S, Nakamura S, et al. Identification of Rapl as a target for the Crk SH3 domain - binding guanine nucleotide - releasing factor C3G [J]. Mol Cell Biol, 1995, 15 (12) : 6746-6753.
  • 8Linghu H, Tsuda M, Makino Y, et al. Involvement of adaptor protein Crk in rnalignan feature of human ovarian cancer cell line MCAS [ J]. Oncogene, 2006, 25 (25): 3547-3556.
  • 9Ten Hoeve J, Morris C, Heisterkamp N, et al. Isolation and chromosomal localization of CRKL, a human crk -like gene [J]. Oneogene, 1993, 8 (9): 2469-2474.
  • 10Jemal A. Cancer statistics[J]. CA Cancer J Clin, 2007, 57(1): 43-66.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部